Copyright
©2014 Baishideng Publishing Group Inc.
World J Diabetes. Oct 15, 2014; 5(5): 651-658
Published online Oct 15, 2014. doi: 10.4239/wjd.v5.i5.651
Published online Oct 15, 2014. doi: 10.4239/wjd.v5.i5.651
Table 1 Use of metformin in chronic kidney disease
| eGFR (mL/min per 1.73 m2) | Use of metformin |
| > 60 (CKD 1 and 2) | No contraindication |
| Check of renal function annually | |
| 45-60 (CKD 3a) | Use of metformin-reduce dose (no more than 1.5-2 g daily) |
| Frequent check of renal function (every 3-6 mo) | |
| 30-45 (CKD 3b) | Reduce dose (no more than 1-1.5 g daily) |
| No new cases | |
| Frequent check of renal function (every 3-6 mo) | |
| < 30 (CKD 4 and 5) | Stop metformin |
- Citation: Ioannidis I. Diabetes treatment in patients with renal disease: Is the landscape clear enough? World J Diabetes 2014; 5(5): 651-658
- URL: https://www.wjgnet.com/1948-9358/full/v5/i5/651.htm
- DOI: https://dx.doi.org/10.4239/wjd.v5.i5.651